| Literature DB >> 34220231 |
Kawther Aabed1, Nadine Moubayed2, Saleha Alzahrani1.
Abstract
Antimicrobial resistance patterns among different Escherichia coli isolates in the Kingdom of Saudi Arabia. This study aimed to investigate the patterns of antimicrobial resistance in E. coli isolated from different samples, and to identify potential pathogenic isolates in Riyadh, Kingdom of Saudi Arabia (KSA). In total, 51 bacterial isolates were recovered from 113 samples of human urine, food (raw meat, raw chicken, raw egg surface, and fresh vegetables), water, and air. Twenty-four E. coli isolates were tested for susceptibility to 26 antibiotics. The air sample isolates were most resistant to amoxicillin, ampicillin, amoxicillin/clavulanic acid, amoxicillin/sulbactam, piperacillin/tazobactam, cefalotin, cefuroxime, cefoxitin, cefixime, nitrofurantoin, and trimethoprim/sulfamethoxazol. The isolates from vegetable samples were resistant to amoxicillin, ampicillin, amoxicillin/clavulanic acid, amoxicillin/sulbactam, cefalotin, cefuroxime, cefoxitin, and cefixime. By contrast, the isolates from the water samples were resistant only to amoxicillin and ampicillin. The isolates from the human urine samples were most frequently resistant to norfloxacin (80%) followed by amoxicillin and ampicillin (70%), trimethoprim/sulfamethoxazole (55%), ciprofloxacin and ofloxacin (50%), cefalotin (30%), cefuroxime, cefixime and cefotaxime (25%), ceftazidime, ceftriaxone, cefepime and aztreonam (20%), amoxicillin/clavulanic acid, piperacillin/tazobactam and gentamicin (10%), and amoxicillin/sulbactam and cefoxitin (5%). Almost all (23/25, 95.8%) (n = 23) of the isolates were multi-drug resistant (MDR) (i.e., resistant to 3 or more classes of antibiotics), and 16.7% (n = 4) of those were positive for extended spectrum β-lactamase (ESBL). Of the 4 ESBL-producers, 3 were positive for blaCTX-M-15 and blaCTX-M1group, 2 were positive for blaCMY-2, and 1 each was positive for blaCTX-M-2 group, blaSHV, and blaOXA-47. The quinolone resistance gene qnrS was detected in 25% (n = 6) of the E. coli strains isolated from urine (N = 5) and air (N = 1) samples. The considerable number of antimicrobial resistance genes detected among E. coli isolates tested here is alarming and should raise public health concern.Entities:
Keywords: Air; Antimicrobial resistance; Escherichia coli; Food, Water; Human urine; Riyadh
Year: 2021 PMID: 34220231 PMCID: PMC8241624 DOI: 10.1016/j.sjbs.2021.03.047
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 2213-7106 Impact factor: 4.219
Primers (Talukdar et al., 2013) used for resistance gene detection.
| Resistance gene | Nucleotide sequence (5’-3’) |
|---|---|
| blaTEM 1150 | TCGGGGAAATGTGCGCG TGCTTAATCAGTGAGGACCC |
| blaSHV 885 | CACTCAAGGATGTATTGTG TTAGCGTTGCCAGTGCTCG |
| blaCTX-M-1group 866 | GGTTAAAAAATCACTGCGTC TTGGTGACGATTTTAGCCGC |
| blaCTX-M-2 group 866 | ATGATGACTCAGAGCATTCG TGGGTTACGATTTTCGCCGC |
| blaCTX-M-8 group 688 | TCGCGTTAAGCGGATGATGC |
| blaCTX-M-9 group 857-870 | ATGGTGACAAAGAGAGTGCA |
| blaCTX-M-15 996 | CACACGTGGAATTTAGGGACT |
| blaOXA-1 group 813 | ACACAATACATATCAACTTCGC |
| blaOXA-47 591- 609 | TCAACTTTCAAGATCGCA |
| blaCMY-2 556 | GACAGCCTCTTTCTCCACA |
| blaNDM-1 465 | GGTTTGGCGATCTGGTTTTC |
| GCTTTCTGCGGGCGATGTAA | |
| CGA AGA AGT AAC AGC CA AG | |
| ATT CTG CCT ATC CTA ATTGG | |
| AGAGGATTTCTCACGCCAGG | |
| GGMATHGAAATTCGCCACTG | |
| GCAAGTTCATTGAACAGGGT TCTAAACCGTCGAGTTCGGCG |
Presence of E. coli isolates in positive cultures.
| Isolated | Food (raw meat) | Fresh vegetables | Water | Air | Urine |
|---|---|---|---|---|---|
| Number of bacteria | 1 | 1 | 1 | 1 | 20 |
| % | 4.2 | 4.2 | 4.2 | 4.2 | 83.3 |
Antibiotic susceptibility patterns of E. coli isolates.
| Antibiotic | R% | I% | S% |
|---|---|---|---|
| Amoxicillin | (70.8)17 | 0 | (29.2)7 |
| Ampicillin | (70.8)17 | 0 | (29.2) 7 |
| Amoxicillin/clavulanic Acid | (16.7)4 | (16.7) 4 | (66.7) 16 |
| Amoxicillin/Sulbactam | (12.5) 3 | 0 | (87.5) 21 |
| Piperacillin/Tazobactam | (12.5) 3 | (12.5) 3 | (75) 18 |
| Cefalotin | (33.3) 8 | (12.5) 3 | (54.2) 13 |
| Cefuroxime | (29.2) 7 | 0 | (70.8)17 |
| Cefoxitin | (12.5) 3 | (4.2) 1 | (83.3) 20 |
| Cefixime | (29.2) 7 | 0 | (70.8)17 |
| Cefotaxime | (20.3) 5 | 0 | (79.2) 19 |
| Ceftazidime | (16.7) 4 | (4.2) 1 | (79.2) 19 |
| Ceftriaxone | (20.3) 5 | 0 | (79.2) 19 |
| Cefepime | (16.7) 4 | 0 | (83.3) 20 |
| Aztreonam | (16.7) 4 | 0 | (83.3) 20 |
| Imipenem | 0 | 0 | (100) 24 |
| Meropenem | 0 | 0 | (100) 24 |
| Amikacin | 0 | (4.2) 1 | (95.8) 23 |
| Gentamicin | (8.3) 2 | 0 | (91.7) 22 |
| Ciprofloxacin | (41.7) 10 | 0 | (58.3) 14 |
| Norfloxacin | (66.7) 16 | – | – |
| Ofloxacin | (41.7)10 | 0 | (58.3) 14 |
| Doxycyclin | – | – | – |
| Minocycline | – | – | – |
| Tigecycline | 0 | 0 | (100) 24 |
| Nitrofurantoin | (4.2) 1 | (12.5) 3 | (83.3) 20 |
| Trimethoprim/Sulfamethoxazole | (50) 12 | 0 | (50) 12 |
R: Resistant, I: Intermediate, S: Susceptible.
Distribution of resistance genes in 24 isolated E. coli isolates.
| Gene | % of gene resistance in 24 identified |
|---|---|
| blaTEM | 12 (50%) |
| blaSHV | 3 (12.5%) |
| blaCTX-M-1group | 7 (29%) |
| blaCTX-M-2 group | 8 (33%) |
| blaCTX-M-8 group | 0 |
| blaCTX-M-9 group | 0 |
| blaCTX-M-15 | 7 (29%) |
| blaOXA-1 group | 1 (4%) |
| blaOXA-47 | 2 (8%) |
| blaCMY-2 | 13 (54%) |
| blaNDM-1 | 0 |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 6 (25%) |
Occurrence of resistance genes in E. coli isolated from different samples.
| Antibiotic resistance pattern | Number | % Percentage of Resistance | Strain number | ESBL gene(s) |
|---|---|---|---|---|
| – | – | – | 2 | |
| Nor** | 1 | 4.2 | 9, 11 | |
| Amx, Amp | 2 | 8.3 | 5, 17 W | |
| Cip, Nor, Ofl, | 3 | 12.5 | 4 | |
| Amx, Amp, Cef, TrSu | 4 | 16.7 | 6 | |
| Amx, Amp, Cip, Nor, Ofl | 5 | 20.9 | 12 | |
| Amx, Amp, Cip, Nor, Ofl, TrSu | 6 | 25 | 3 | |
| Amx, Amp, Gen, Cip, Nor, Ofl, TrSu | 7 | 29.2 | 16 | |
| Amx, Amp, AmCl, AmSu, Cef, Cur, Cox, Cix | 8 | 33.3 | Q14 | |
| Amx, Amp, AmCl, AmSu, Cef, Cur, Cox, Cix, Nir, TrSu | 10 | 41.7 | 13A | |
| Amx, Amp, Cef, Cur, Cix, Cot, Cta, Ctr, Cep, Azt, Nor, TrSu | 12 | 50 | 10* | blaSHV |
| Amx, Amp, Cef, Cur, Cix, Cot, Cta, Ctr, Cep, Azt, Cip, Nor, Ofl | 13 | 54.2 | 1* | blaCTX-M-1group, blaCTX-M-15, blaCMY-2 |
| Amx, Amp, Cef, Cur, Cix, Cot, Cta, Ctr, Cep, Azt, Cip, Nor, Ofl, TrSu | 14 | 58.3 | 7* | blaCTX-M-1group, blaCTX-M-2 group, blaCTX-M-15, blaCMY-2 |
| Amx, Amp, AmCl, PiTa, Cef, Cur, Cix, Cot, Cta, Ctr, Cep, Azt, Nor, TrSu | 14 | 58.3 | 18* | blaTEM, blaCTX-M-1group, blaCTX-M-15, blaOXA-47, qnrS |
| Amx, Amp, AmCl, AmSu, PiTa, Cef, Cur, Cix, Cot, Ctr, Gen, Cip, Nor, Ofl, TrSu | 15 | 62.5 | 8 |
* ESBL (+) strains; **Amx, Ampicillin; Amp, Ampicillin; AmCl , Amoxicillin/clavulanic Acid; AmSu, Amoxicillin/Sulbactam; PiTa, Piperacillin/Tazobactam; Cef, Cefalotin; Cur, Cefuroxime; Cox, Cefoxitin; Cix, Cefixime; Cot, Cefotaxime; Cta, Ceftazidime; Ctr, Ceftriaxone; Cep, Cefepime; Azt, Aztreonam; Imi, Imipenem; Mer, Meropenem; Ami, Amikacin; Gen, Gentamicin; Cip, Ciprofloxacin; Nor, Norfloxacin; Ofl, Ofloxacin; Dox, Doxycycline; Min, Minocycline; Tig, Tigecycline; Nir, Nitrofurantoin; and TrSu, Trimethoprim/Sulfamethoxazole;. (1–20) urine samples, (21) ATCC 25922, (M) meat samples, (W) water samples, and (A) air samples.
Fig. 1Image of ESBL genes, confirmed in ESBL-producing E. coli strains (1, 7, 18 numbered strains) on an agarose gel. Gene Ruler DNA ladder was used as size marker.
Fig. 2Image of ESBL genes, confirmed in ESBL-producing E. coli strains (1, 7, 10 numbered strains) on an agarose gel. Gene Ruler DNA ladder was used as size marker.